ICD10 code of Gaucher Disease and ICD9 code

The primary ICD-10 code for Gaucher disease is E75.22, while the corresponding ICD-9 code is 272.7. These diagnostic codes are essential for healthcare providers to accurately document and bill for the clinical management of this lysosomal storage disorder.

What exactly is Gaucher disease?

Gaucher disease is a rare, inherited metabolic disorder characterized by the deficiency of the enzyme glucocerebrosidase. This deficiency leads to the accumulation of a fatty substance called glucocerebroside within the cells of the spleen, liver, bone marrow, and—in specific subtypes—the central nervous system. Because it is a systemic condition, Gaucher disease requires a multidisciplinary approach to care, involving hematologists, metabolic specialists, and genetic counselors. Within the DiseaseMaps community, 84 people with Gaucher disease have shared their experiences, highlighting the importance of specialized tracking and coding for long-term health monitoring.

How are the ICD-10 and ICD-9 codes used for Gaucher disease?

Medical coding is the bridge between clinical diagnosis and the healthcare system. Using the correct code ensures that patients receive appropriate coverage for specialized treatments, such as Enzyme Replacement Therapy (ERT) or substrate reduction therapy. While ICD-10-CM code E75.22 is the specific identifier for Gaucher disease, clinicians may also use supplemental codes to document specific manifestations of the condition, such as hepatosplenomegaly or thrombocytopenia. Accurate coding is vital not only for insurance purposes but also for tracking the prevalence and clinical outcomes of Gaucher disease in international health registries.

What are the different clinical types of Gaucher disease?

The clinical presentation of Gaucher disease is typically categorized into three main types based on the presence and severity of neurological involvement:

• Type 1 (Non-neuropathic): The most common form in Western countries, typically affecting the liver, spleen, bones, and blood cells, but sparing the brain.


• Type 2 (Acute neuropathic): A rare, severe form characterized by early-onset, progressive brainstem involvement and neurological decline during infancy.


• Type 3 (Chronic neuropathic): An intermediate form that involves both systemic organ involvement and slower, progressive neurological symptoms.

Is Gaucher disease hereditary?

Yes, Gaucher disease is an autosomal recessive disorder. This means that an individual must inherit two mutated copies of the GBA1 gene—one from each parent—to manifest the condition. Parents who are carriers of the gene mutation typically do not show symptoms themselves but have a 25% chance of passing the condition to each child. Genetic testing and counseling are strongly recommended for families affected by Gaucher disease to understand inheritance risks and family planning options.

Next steps

• Consult with a metabolic specialist or a hematologist who has specific experience in treating lysosomal storage disorders.


• Verify that your medical records and insurance authorizations correctly reflect the E75.22 ICD-10 code to ensure access to necessary therapies.


• Connect with the 84 members of the DiseaseMaps community living with Gaucher disease to share resources and personal experiences.


• Request a referral to a clinical geneticist to discuss carrier screening for family members.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Gaucher Disease Overview.


• Orphanet: Rare Disease Database (ORPHA:355).


• OMIM (Online Mendelian Inheritance in Man): Entry #230800 (Gaucher Disease).


• National Gaucher Foundation: Clinical Resource Center.